Wells Fargo & Company Karyopharm Therapeutics Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 33,898 shares of KPTI stock, worth $30,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,898
Previous 29,365
15.44%
Holding current value
$30,169
Previous $25,000
104.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding KPTI
# of Institutions
121Shares Held
72.4MCall Options Held
476KPut Options Held
175K-
Black Rock Inc. New York, NY9.45MShares$8.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.34MShares$7.42 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX8.3MShares$7.39 Million0.48% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$4.54 Million0.9% of portfolio
-
Eversept Partners, LP New York, NY5.02MShares$4.46 Million0.57% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $71M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...